Drugs / umbilical cord-derived mesenchymal stem cell
umbilical cord-derived mesenchymal stem cell
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT06578039 | Aug 2024 → Apr 2025 | primary ovarian failure | CHABiotech CO., Ltd | Completed | No outcome recorded |
| Phase 1/23 trials | ||||||
| Phase 1/2 | NCT05345418 | Apr 2022 → Jun 2025 | sexual disorder | Vinmec Research Institute of Stem Cell and Gene Technology | Unknown | No outcome recorded |
| Phase 1/2 | NCT04522869 | Aug 2019 → Sep 2021 | primary biliary cholangitis | Vinmec Research Institute of Stem Cell and Gene Technology | Completed | No outcome recorded |
| Phase 1/2 | NCT03847844 | Feb 2019 → Jul 2023 | acute graft versus host disease | Cytopeutics Sdn. Bhd. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT03945487 | May 2019 → Dec 2021 | cirrhosis of liver | Beijing 302 Hospital | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07605559 | May 2026 → Dec 2027 expected | rotator cuff syndrome | Kyoung Hwan Koh | Not yet recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Umbilical Cord Derived Mesenchymal Stem Cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04522869 ↗ |
| Known as | UC -MSC | “Our and other previous studies have demonstrated that marrow bone-derived mesenchymal stem cells (BM-MSC) or unbilical cord derived MSC (UC-MSC) infusion is clinically safe and...” NCT03945487 ↗2“Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Liver Cirrhosis Due to Biliary Atresia” NCT04522869 ↗ “A validated umbilical cord blood mesenchymal stem cells (UC-MSC) line was selected from the Vinmec Tissue Bank” NCT05345418 ↗ |
| Known as | VCELL 1 | “Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency” NCT05345418 ↗ |
| Modality | Cell therapy | “allogeneic infusion of Cytopeutics® umbilical cord-derived mesenchymal stromal cells (Cyto-MSC)” NCT03847844 ↗ |
| Route | Intravenous | “Taken a dose of 1.0\*10E6 UC-MSC/kg body weight intravenously three times at 3-week intervals, in addition to comprehensive treatment.” NCT03945487 ↗ |